Drug: TRUVADA Injury: Viral mutation identified Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125534381 | TRUVADA | Viral mutation identified | GILEAD | 34.00 YR | M | 0 | 20160713 | FR |
125547411 | TRUVADA | Viral mutation identified | GILEAD | 68.00 YR | M | 0 | 20160713 | CA |
125664701 | TRUVADA | Viral mutation identified | GILEAD | 51.00 YR | M | 0 | 20160718 | CA |
125697051 | TRUVADA | Viral mutation identified | VIIV | 0.00 | M | 0 | 20160719 | CA |
125698861 | TRUVADA | Viral mutation identified | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160719 | CA |
125813132 | TRUVADA | Viral mutation identified | GILEAD | 0.00 | M | 0 | 20160803 | US |
125882072 | TRUVADA | Viral mutation identified | GILEAD | 69.00 YR | M | 0 | 20160901 | CA |
126668391 | TRUVADA | Viral mutation identified | BRISTOL MYERS SQUIBB | 34.00 YR | M | 0 | 20160819 | FR |
Total Records: 8 Number of Pages: 1